Roxithromycin and erythromycin in chlamydia-negative non-gonococcal urethritis.
DOI:
https://doi.org/10.2340/0001555570269271Abstract
The clinical efficacy and safety of roxithromycin 300 mg once a day was compared with that of erythromycin 500 mg twice a day in 87 men with chlamydia-negative non-gonococcal urethritis. In the roxithromycin group the clinical efficacy rate was 88% on day 8 and between 78% and 84% on day 21. In the erythromycin group the clinical efficacy rate was 98% on day 8 and 86% on day 21, a non-significant difference. Side effects were mainly gastrointestinal, occurring in about 15% of patients receiving each treatment.Downloads
Download data is not yet available.
Downloads
Published
1990-05-01
How to Cite
Worm, A. M. (1990). Roxithromycin and erythromycin in chlamydia-negative non-gonococcal urethritis. Acta Dermato-Venereologica, 70(3), 269–271. https://doi.org/10.2340/0001555570269271
Issue
Section
Articles
License
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
